These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38773753)

  • 1. Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.
    Whitaker H; Findlay B; Zitha J; Goudie R; Hassell K; Evans J; Kalapotharakou P; Agrawal U; Kele B; Hamilton M; Moore C; Byford R; Stowe J; Robertson C; Couzens A; Jamie G; Hoschler K; Pheasant K; Button E; Quinot C; Jones T; Anand S; Watson C; Andrews N; de Lusignan S; Zambon M; Williams C; Cottrell S; Marsh K; McMenamin J; Lopez Bernal J
    Influenza Other Respir Viruses; 2024 May; 18(5):e13284. PubMed ID: 38773753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain.
    Whitaker HJ; Willam N; Cottrell S; Goudie R; Andrews N; Evans J; Moore C; Agrawal U; Hassell K; Gunson R; Zitha J; Anand S; Sebastian-Pillai P; Kalapotharakou P; Okusi C; Hoschler K; Jamie G; Kele B; Hamilton M; Couzens A; Quinot C; Pheasant K; Byford R; Marsh K; Robertson C; de Lusignan S; Williams C; Zambon M; McMenamin J; Watson CH
    Influenza Other Respir Viruses; 2024 May; 18(5):e13295. PubMed ID: 38744684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.
    Pebody RG; Whitaker H; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Thompson C; Galiano M; Lackenby A; Robertson C; O'Doherty MG; Owens K; Yonova I; Shepherd SJ; Moore C; Johnston J; Donati M; McMenamin J; Lusignan S; Zambon M
    Vaccine; 2020 Jan; 38(3):489-497. PubMed ID: 31685296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18.
    Pebody R; Djennad A; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Galiano M; Hoschler K; Lackenby A; Robertson C; O'Doherty M; Sinnathamby M; Panagiotopoulos N; Yonova I; Webb R; Moore C; Donati M; Sartaj M; Shepherd SJ; McMenamin J; de Lusignan S; Zambon M
    Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.
    Yaron-Yakoby H; Sefty H; Pando R; Dichtiar R; Katz MA; Stein Y; Mandelboim M; Mendelson E; Shohat T; Glatman-Freedman A;
    Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.
    Kissling E; Rose A; Emborg HD; Gherasim A; Pebody R; Pozo F; Trebbien R; Mazagatos C; Whitaker H; Valenciano M;
    Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results.
    Pebody RG; Warburton F; Ellis J; Andrews N; Thompson C; von Wissmann B; Green HK; Cottrell S; Johnston J; de Lusignan S; Moore C; Gunson R; Robertson C; McMenamin J; Zambon M
    Euro Surveill; 2015 Feb; 20(5):21025. PubMed ID: 25677050
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17.
    Pebody RG; Warburton F; Andrews N; Sinnathamby M; Yonova I; Reynolds A; Robertson C; Cottrell S; Sartaj M; Gunson R; Donati M; Moore C; Ellis J; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2018 Sep; 23(39):. PubMed ID: 30280688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
    Chung JR; Kim SS; Kondor RJ; Smith C; Budd AP; Tartof SY; Florea A; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Reis M; Geffel KM; Nowalk MP; DaSilva J; Keong LM; Stark TJ; Barnes JR; Wentworth DE; Brammer L; Burns E; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):365-370. PubMed ID: 35271561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
    Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
    Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
    [No Abstract]   [Full Text] [Related]  

  • 14. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.
    Rose A; Kissling E; Emborg HD; Larrauri A; McMenamin J; Pozo F; Trebbien R; Mazagatos C; Whitaker H; Valenciano M;
    Euro Surveill; 2020 Mar; 25(10):. PubMed ID: 32183932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.
    Ando S
    Intern Med; 2020 Apr; 59(7):933-940. PubMed ID: 31787695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023.
    Chung JR; Shirk P; Gaglani M; Mutnal MB; Nowalk MP; Moehling Geffel K; House SL; Curley T; Wernli KJ; Kiniry EL; Martin ET; Vaughn IA; Murugan V; Lim ES; Saade E; Faryar K; Williams OL; Walter EB; Price AM; Barnes JR; DaSilva J; Kondor R; Ellington S; Flannery B
    Influenza Other Respir Viruses; 2024 Jun; 18(6):e13342. PubMed ID: 38923314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
    Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results.
    Pebody R; Warburton F; Andrews N; Ellis J; von Wissmann B; Robertson C; Yonova I; Cottrell S; Gallagher N; Green H; Thompson C; Galiano M; Marques D; Gunson R; Reynolds A; Moore C; Mullett D; Pathirannehelage S; Donati M; Johnston J; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2015; 20(36):. PubMed ID: 26535911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.